Audited Supplier
In This Store
Category:Active Pharmaceutical Ingredients > Biochemical Ingredients > Peptides
Product Name:Retatrutide 2381089-83-2
CAS No.:2381089-83-2
Standard:ChP, USP, BP, EP, JP, In-house Standards, IP, Ph. Int
Price(USD):Negotiable
Company:Harbin Jixianglong Biotech Co., Ltd.
Grade: Pharmaceutical Grade
Factory Location: Harbin, China
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Monthly Production Capacity: 100kg/Month
Contract Manufacturing: CRO,CMO
Packaging Information: Aluminium Foil Bag, Bottle etc.
Delivery Lead Time: 7 days
Sample Provided: yes
Payment Terms: T/T
Retatrutide CAS No. 2381089-83-2
Retatrutide is a novel triple agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1 and glucagon receptors.
Retatrutide is a triple hormone (GIP, GLP-1 and glucagon) receptor agonist in development for the treatment of obesity.
Retatrutide is also being studied for the treatment of type 2 diabetes mellitus.
| Product Name | Retatrutide |
| CAS NO. | 2381089-83-2 |
| Appearance | White Powder |
| Purity | 99% or customized |
| Application | Drug peptides |
| Usage | Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. Help people with obesity lose weight. |
Mobile / Wechat： 13613621816（微信同号）
QQ: 2030459456
Related Products
| Name | CAS No. | Name | CAS No. |
| Eptifibatide | 188627-80-7 | Thymalfasin | 69440-99-9 |
| Terlipressin Acetate | 14636-12-5 | Thymopentin Acetate (TP-5) | 69558-55-0 |
| Astosiban Acetate | 90779-69-4 | Octreotide Acetate | 83150-76-9 |
| Liraglutide | 204656-20-2 | Melanotan II Acetate | 121062-08-6 |
| Teriparatide | 52232-67-4 | Melanotan I Acetate | 75921-69-6 |
| Bivalirudin | 128270-60-0 | Secretin Acetate | 17034-35-4 |
| Carbetocin | 37025-55-1 | Ornipressin Acetate | 3397-23-7 |
| Thymosin Beta 4 | 77591-33-4 | Oxytocin Acetate | 50-56-6 |
| Calcitonin | 60731-46-6 | Lypressin Acetate | 50-57-7 |
| Semaglutide | 910463-68-2 | Argpressin Acetate | 113-79-1 |
| Abaloparatide | 247062-33-5 | Calcitonin (Salmone) Acetate | 47931-85-1 |
Company Profile
Founded in 2011, Harbin Jixianglong Biotech Co., Ltd. is a is a professional high-tech company specializing in R&D and production of polypeptide pharmaceuticals. Our advanced industry chain occupied in R&D, approbation and industrialization of peptides API and preparation.
Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.
Main Products:
10 items completed polypeptide API declared:
Eptifibatide, Somatostatin, Terlipressin Acetate, Thymalfasin, Atosiban Acetate, Carbetocin, Oxytocin, Ganirelix Acetate, Octreotide Acetate, Cetrorelix Acetate.
N items as researching reserve series:
Teriparatide, Bivalirudin, Liraglutide, Nesiritide, Abaloparatide, Semaglutide, Personalized cancer neoantigen peptide vaccine, Peptide drug conjugate (PDC).
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us：
Pharma Sources Insight June 2024: Globalization on the Go
